MetaVia Inc Sustainability Reports
MetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. The company is currently developing therapeutic candidates for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH).
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
1 reports from 2024 to 2024
Company Profile
MetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. The company is currently developing therapeutic candidates for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH).
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
